It spreads particularly easily in close quarters, including daycares, cruise ships, universities and nursing homes. Norovirus ...

Moderna stock jumped Tuesday after the first bird-flu death was reported in the U.S.Shares were up 10.6% to $47.10 in early ...

With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more here.

Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.

A statewide grand jury didn’t find evidence that COVID-19 vaccine manufacturers broke federal or state laws when making and ...

In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...

Investors should be aware of 2025 headwinds, including declining COVID-19 vaccine sales and potential regulatory impacts from RFK Jr.'s appointment. During the pandemic, Moderna took advantage of ...